annb0t
Top 20
ResMed Inc. RMD has been gaining from the robust performance in the Software-as-a-Service ("SaaS") business. The ongoing rebound in device sales within the companyâs Sleep and Respiratory Care segment instills optimism. The robust performance across high-growth markets is an added advantage. However, mounting expenses and stiff competition raise apprehension.
Over the past year, the Zacks Rank #3 (Hold) stock has gained 38% against an 17.4% fall of the industry. Notably, the S&P 500 has ri...
>>> Read more: Here's Why You Should Retain ResMed (RMD) Stock for Now
Over the past year, the Zacks Rank #3 (Hold) stock has gained 38% against an 17.4% fall of the industry. Notably, the S&P 500 has ri...
>>> Read more: Here's Why You Should Retain ResMed (RMD) Stock for Now
